Literature DB >> 8287627

Immunohistochemistry of synapsin I and synaptophysin in human nervous system and neuroendocrine tumors. Applications in diagnostic neuro-oncology.

T W Smith1, S Nikulasson, U De Girolami, L J De Gennaro.   

Abstract

Synapsin I is a phosphoprotein localized to the cytoplasmic surface of synaptic vesicles and is one of the best characterized neuron-specific proteins. Synaptophysin is an integral membrane glycoprotein, also located on presynaptic vesicles, which has been shown to be a useful immunohistochemical marker for neuroendocrine/neuronal differentiation in tumor diagnosis. The sensitivity and specificity of immunohistochemical staining for these two proteins in formalin-fixed, paraffin-embedded tissues was studied in a series of 67 neuroectodermal, neuroendocrine, and non-neural tumors. Intense immunoreactivity for both synapsin I and synaptophysin was observed in tumors containing well-differentiated neurons (gangliocytoma, ganglioglioma, neurocytoma). In these tumors, immunostaining was primarily concentrated along the outer surface of the cell membrane of the neuronal cells. Primitive neuroectodermal tumors (PNETs) (cerebral PNET, medulloblastoma, neuroblastoma) and most neuroendocrine tumors generally showed less intense and more variable immunoreactivity for these proteins. In most cases, immunostaining for synapsin I was sharper and often more intense than for synaptophysin. Some PNETs and neuroendocrine tumors that were immunoreactive for synapsin I did not stain for synaptophysin. We conclude that synapsin I is a reliable, sensitive immunohistochemical marker for neuronal/neuroendocrine differentiation in human neoplasms and may offer some advantages over synaptophysin when applied to formalin-fixed, paraffin-embedded tissues, particularly in the evaluation of primitive neuroectodermal tumors and neuroendocrine tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287627

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  10 in total

1.  Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping.

Authors:  D Krex; B Mohr; M Hauses; G Ehninger; H K Schackert; G Schackert
Journal:  J Neurooncol       Date:  2001-04       Impact factor: 4.130

Review 2.  Classic and recent special stains used in differential diagnosis of endocrine tumors.

Authors:  G Bussolati; M Volante; M Papotti
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

3.  Lack of protein-tyrosine sulfation disrupts photoreceptor outer segment morphogenesis, retinal function and retinal anatomy.

Authors:  David M Sherry; Anne R Murray; Yogita Kanan; Kelsey L Arbogast; Robert A Hamilton; Steven J Fliesler; Marie E Burns; Kevin L Moore; Muayyad R Al-Ubaidi
Journal:  Eur J Neurosci       Date:  2010-10-12       Impact factor: 3.386

4.  Immunocytochemical evidence for SNARE protein-dependent transmitter release from guinea pig horizontal cells.

Authors:  Helen Lee; Nicholas C Brecha
Journal:  Eur J Neurosci       Date:  2010-04-06       Impact factor: 3.386

5.  GABA activity mediating cytosolic Ca2+ rises in developing neurons is modulated by cAMP-dependent signal transduction.

Authors:  K Obrietan; A N van den Pol
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

6.  Cellular distribution and subcellular localization of molecular components of vesicular transmitter release in horizontal cells of rabbit retina.

Authors:  Arlene A Hirano; Johann H Brandstätter; Nicholas C Brecha
Journal:  J Comp Neurol       Date:  2005-07-18       Impact factor: 3.215

7.  Oncogenic BRAFV600E induces expression of neuronal differentiation marker MAP2 in melanoma cells by promoter demethylation and down-regulation of transcription repressor HES1.

Authors:  Nityanand Maddodi; Kumar M R Bhat; Sulochana Devi; Su-Chun Zhang; Vijayasaradhi Setaluri
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

8.  Differential developmental deficits in retinal function in the absence of either protein tyrosine sulfotransferase-1 or -2.

Authors:  David M Sherry; Yogita Kanan; Robert Hamilton; Adam Hoffhines; Kelsey L Arbogast; Steven J Fliesler; Muna I Naash; Kevin L Moore; Muayyad R Al-Ubaidi
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

9.  Distribution of plasma membrane-associated syntaxins 1 through 4 indicates distinct trafficking functions in the synaptic layers of the mouse retina.

Authors:  David M Sherry; Robert Mitchell; Kelly M Standifer; Brad du Plessis
Journal:  BMC Neurosci       Date:  2006-07-13       Impact factor: 3.288

10.  Primitive neuroectodermal kidney tumour.

Authors:  M S Khan; R A Stewart; H Vazir; A O'Brien
Journal:  Ulster Med J       Date:  1995-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.